These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [New trends in the treatment of amyloidosis]. Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598 [TBL] [Abstract][Full Text] [Related]
12. Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis. Clos AL; Lasagna-Reeves CA; Kelly B; Wagner R; Wilkerson M; Jackson GR; Kayed R J Am Acad Dermatol; 2011 Nov; 65(5):1023-31. PubMed ID: 21669474 [TBL] [Abstract][Full Text] [Related]
13. A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis. Matsuura M; Abe H; Tominaga T; Sakurai A; Murakami T; Kishi S; Bando Y; Minakuchi J; Nagai K; Doi T J Med Invest; 2017; 64(3.4):217-221. PubMed ID: 28954985 [TBL] [Abstract][Full Text] [Related]
14. Methods to study the structure of misfolded protein states in systemic amyloidosis. Fändrich M; Schmidt M Biochem Soc Trans; 2021 Apr; 49(2):977-985. PubMed ID: 33929491 [TBL] [Abstract][Full Text] [Related]
15. Current concepts on the pathogenesis of systemic amyloidosis. Bellotti V; Merlini G Nephrol Dial Transplant; 1996; 11 Suppl 9():53-62. PubMed ID: 9050036 [TBL] [Abstract][Full Text] [Related]